Infectious Disease & Vaccines
| 5 min read
New population-level data reveal unprecedented declines in cervical cancer among vaccinated cohorts, even as vaccination rates begin to slip in some countries.
| 5 min read
The approach identifies entirely new chemical structures that could help replenish a thinning antibiotic pipeline as resistance continues to rise.
| 3 min read
As a new wave of chronic cough therapeutics enters clinical development, researchers are questioning whether the tools used to measure treatment effects are up to the task.
| 4 min read
Two reports landed the same week: one documenting rising pandemic risk, the other showing how little of the antiviral pipeline is ready to meet it. Then Ebola was declared a public health emergency.
| 4 min read
A first-in-human trial shows how computationally designed antigens could help shift vaccines from reactive to future-proof.
| 4 min read
Microbubble-based genetic medicines, pharma deals, trial misses, and more led the news this week.
Mass photometry helps researchers investigate the large and dynamic molecular assemblies that drive HIV integration and influence antiviral drug development.
| 3 min read
Researchers developed a highly tolerable oral antiviral against orthoparamyxoviruses like measles and human parainfluenza virus types 1 and 3.
| 4 min read
FDA approvals, pharma deals, and genetic testing advancements led the news this week.
| 4 min read
Hidden proteins reveal new drug targets, FDA tool upgrades, pharma deals, and more led the news this week.
| 3 min read
New findings suggest that the location of mRNA expression in the body plays a critical role in shaping T cell responses, opening the door to more precise and effective mRNA-based treatments.
| 4 min read
A multicountry study shows that a point-of-care TB test performs comparably to established molecular diagnostics while offering a simpler workflow and faster turnaround.
